AQR Capital Management - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 236 filers reported holding BEAM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$375,417
-18.2%
9,599
-0.4%
0.00%0.0%
Q3 2022$459,000
-22.5%
9,641
+29.9%
0.00%0.0%
Q4 2021$592,000
-70.1%
7,424
-67.3%
0.00%
-75.0%
Q3 2021$1,978,000
-16.9%
22,728
+22.9%
0.00%0.0%
Q2 2021$2,381,000
+182.8%
18,500
+75.8%
0.00%
+300.0%
Q1 2021$842,000
+22.7%
10,521
+25.3%
0.00%0.0%
Q4 2020$686,0008,3990.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$304,095,00029.88%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO 224,391$28,881,00022.15%
HSG Holding Ltd 796,089$102,465,0007.14%
DC Investments Management, LLC 21,010$2,704,0006.36%
PATHWAY CAPITAL MANAGEMENT, LP 112,197$14,441,0005.74%
Redmile Group, LLC 2,052,506$264,178,0003.91%
Casdin Capital, LLC 818,820$105,390,0002.68%
Darwin Global Management, Ltd. 126,985$16,344,0002.64%
Evolutionary Tree Capital Management, LLC 44,032$5,667,0002.61%
HHLR ADVISORS, LTD. 1,845,753$237,567,0002.44%
View complete list of BEAM THERAPEUTICS INC shareholders